Future Ventures: Scaling with Clarity

Send us Fan Mail

Alan McLaren is the co-founder of Strata Originals, where he helps CEOs, founders, and executive teams understand one of the most overlooked forces in leadership: how they are actually experienced by other people. His work sits at the intersection of leadership, storytelling, trust, brand, and high-stakes communication. In these rooms, investors, boards, teams, and buyers often make decisions before anyone says the quiet part out loud. 

This conversation is important because most leaders think they're judged by their strategy, intelligence, or words. Alan explains that people can often tell who you are even before you speak. Max and Alan talk about how pressure can show hidden leadership problems, why trust can break in small moments, and how founders trying to raise money, lead teams, or sell their businesses should be aware of the signals they send when things get tense. 

5 Key Topics Covered 

• Leadership Signal — why the way a founder lands in the room can determine whether people align, hesitate, or quietly disengage. 
• Pressure and distortion — how challenges to identity, credibility, or authority can trigger reactions leaders do not even realize they are broadcasting. 
• Trust in capital and boardrooms — why investors, teams, and acquirers are constantly asking whether they feel safe and whether they trust the person leading. 
• Founder bottlenecks and valuation risk — how a business that depends too heavily on one person becomes harder to scale, delegate, and sell. 
• The evolution of the CEO role — why leaders move from doing everything, to delegating, to becoming the bandleader responsible for vision, culture, and trust. 

3 Key Insights 

1. Leadership is not just communication. A founder can say the right words and still lose the room if their tone, posture, defensiveness, or energy sends a different signal. 
2. Trust breaks faster than most leaders realize. One dismissive comment, one defensive reaction, or one moment of command-and-control behaviour can shut people down long before the meeting ends. 
3. Scale requires the founder to become less central to the machine. The stronger the team, the clearer the delegation, and the lower the key-person risk, the more valuable and durable the business becomes. 

Links 

● Strata Originals: https://ca.linkedin.com/company/strataoriginals 

● Alan McLaren on LinkedIn: https://ca.linkedin.com/in/alanmclaren 

● Future Ventures Corp: https://ca.linkedin.com/company/future-ventures-corp

About the Guest

Alan McLaren is the co-founder of Strata Originals, a company that helps leaders improve how they perform in stressful situations. He used to run a marketing agency for almost twenty years before switching to work on leadership, branding, and building trust. Now, Alan helps founders and CEOs spot hidden signals and misunderstandings that affect how they lead, get funding, build teams, and grow their businesses. 

Send us Fan Mail

In a moment where everyone is racing to build with AI, Dennis Bruce is the voice telling founders to slow down enough to know where they're going. With more than three decades navigating large-scale technology transformations — from integrating minicomputers and mainframes at the UN in the 1980s, to rebuilding the privatized Entel (now Telecom Argentina) during Latin America's privatization wave, to turnarounds across airports, retail, and property management — Dennis has seen every flavor of ambitious tech project. In 2007, he founded Tangonet Solutions, which today collaborates with 200+ technology professionals across the Americas, pairing North American companies with deep Argentine engineering talent to close the gap between business strategy and technical execution. 

This conversation matters because it punctures the hype without dismissing the technology. Dennis is bullish on AI — but he's blunt about what it can't do. You can generate 30,000 lines of code in seconds; you cannot vibe-code your way to an enterprise. Maxim and Dennis dig into why most projects still fail, what separates a weekend prototype from a production system, and why — after all the talk about models and tooling — the hardest part of any transformation is still people. If you're a founder deciding whether to build, buy, or go to market, this episode gives you a sharper lens. 

5 Key Topics Covered 

• The "Ferrari" problem — AI lets you move faster than ever, but speed only matters if you actually know your destination. 
• Why projects really fail — most teams build before they understand the outcome, and discover product-market fit too late. 
• Prototype vs. enterprise — the leap from a Replit or Cursor demo to a maintainable, secure, scalable system is where the real work lives. 
• People are the weakest link — governance and process you can engineer, but change management and sponsorship decide whether anything ships. 
• The tooling shift — why Claude Code has become the standard, how Whisperflow changes daily workflow, and the case for going all in on one stack. 

3 Key Insights 

1. AI has driven the cost of building toward zero, but not the cost of knowing what to build — so the durable advantage is no longer the code itself, but distribution, proprietary data, or genuine speed to market. 
2. Raw output is a vanity metric; teams that skip software-engineering fundamentals end up funding teardowns and "rescue projects" that cost far more than doing it right the first time. 
3. The smartest move with an internal tool often isn't taking it to market — it's using it to make your own business faster and more efficient, turning the build into a competitive edge rather than another product fighting for oxygen. 

Links 

• Tangonet Solutions: https://tangonetsolutions.com/ 
• Dennis Bruce on LinkedIn: https://www.linkedin.com/in/dennisbrucetechgrowth/es 
• Future Ventures Corp: https://ca.linkedin.com/company/future-ventures-corp 
• Subscribe to Scaling with Clarity: https://www.youtube.com/@Future.Ventures 

 About the Guest 

Dennis Bruce is the General Director of Tangonet Solutions, with more than 30 years of experience in technology projects across the Americas. He has worked on projects like integrating UN systems, selling Argentina's telecom industry to private companies, and helping big companies update their technology. Today, he helps businesses find top Argentine engineers to turn their plans into real results. 

Send us Fan Mail

Damian Roller is a Partner at Inovexus, a community-backed founders club that invests in and supports early-stage European startups across the DACH region — Germany, Austria, and Switzerland. Before backing founders, he was one: born in Poland, raised in Germany, he built and sold an e-commerce company at university, spent a couple of years day trading and in real estate, then joined the founding team of a Munich B2B SaaS company in 2016. Eight years, one pandemic, and one exit later, he came out the other side with a hard-won operator's view of what scaling actually takes. Today, he helps run a network of 2,500+ investors and roughly 500 mentors — people who have already done the thing the founder in front of them is trying to do. 

This conversation is important because Damian is at the point where most founders get stuck: the difference between building a product and scaling a business. His main point is direct and timely — AI has made building cheaper, so now what sets you apart is distribution. This change changes how founders should think about raising money, choosing mentors, entering markets, and deciding whether to build or buy, which can quietly cause companies to fail. If you're a founder deciding whether to grow, seek funding, or just focus on shipping, this episode helps you see things more clearly. 

Key topics covered 

• The Inovexus model — How a founders club backed by experienced angels and operator-mentors invests deal-by-deal and stays on the journey long-term, not just for a cohort. 
• AI and the disappearing moat — Why a three-person team can now do what once took fifteen, and why that makes go-to-market the real battleground. 
• The real bottleneck — Damian's case that capital is rarely the constraint; closing a founder's knowledge gaps is. 
• Why Europe taxes its founders — How fragmented languages, regulations, and sales cultures force European startups to win country by country, and what that means for the jump to the US. 
• The B2B SaaS "apocalypse" and build-vs-buy — Whether AI wipes out software companies, and the total-cost-of-ownership math that founders underestimate. 

Three key insights 

1. When building gets cheap, distribution becomes the moat. The hard problem shifts from making the product to reaching customers across fragmented markets — which is precisely where a strong network and operator mentorship earn their keep. 
2. Capital is rarely the bottleneck; standing still is. A skilled founder usually has a clear product vision but may overlook some things. The right mentor helps guide the process, turning a long search into a more direct path from start to finish. 
3. Europe's fragmentation is a real cost, but a shrinking one. Winning market by market is a tax on European founders — yet cross-border thinking is becoming a core founder skill, and rushing to the US unprepared punishes more often than it rewards. 

Links 

• Inovexus: https://inovexus.com/ 
• Damian Roller on LinkedIn: https://de.linkedin.com/in/damianroller 
• Future Ventures: https://ca.linkedin.com/company/future-ventures-corp 
• Scaling with Clarity: https://www.linkedin.com/showcase/futureventures-podcast/ 

About the guest 

Damian Roller is a Partner at Inovexus and co-founder of its German entity, expanding the firm's model across the DACH region. A four-time builder turned investor, he started and sold his first company at university before helping found and scale a Munich-based B2B SaaS company to a successful exit over eight years. He now spends his days finding strong founders and connecting them to a community of 2,500+ investors and roughly 500 operator-mentors. 

This episode of Scaling with Clarity has been brought to you by the Capital Intelligence Platform — capital.futureventures.ca 

Send us Fan Mail

Robert Stanley isn't a healthcare lifer. He spent most of his career in technology — running IT projects for big banks, telcos, and airlines — before moving into home care about a decade ago and building one of Ontario's established providers. That outsider's vantage point is exactly what makes this conversation worth your time. Where insiders see a system to optimize, Robert sees one that's structurally broken: wired to reward visits, procedures, and ambulance rides, with almost nothing that pays anyone to prevent the crisis in the first place. The math behind his urgency is hard to argue with — Canada's population of 82-year-olds peaks around 2051, and demand only climbs from here. 

His idea is called Comprehensive Healthcare at Home: continuously monitor at-risk seniors and send a nurse or therapist when something seems wrong — often weeks before it would lead to an emergency room visit. But what makes CHA different isn't just the technology. It's how he set it up. Robert launched the care company first and treated it as a testing ground, so the technology became part of routines his clinicians already trusted, rather than being added on top. That's the key difference because most healthcare trials fail not because of the idea itself, but because they don’t fit into the busy schedule of overworked clinicians. For entrepreneurs facing a slow, regulated market, this is a lesson in earning the right to make changes. 

Topics Covered 

• The prevention problem — why a system that funds episodic care has no incentive to stop the crisis before it happens. 
• Building care first, tech second — how running a home care company turned product-market fit into a non-question. 
• Ambient monitoring in practice — optical sensors, smart mattresses, and predicting falls up to four weeks out. 
• Data as the long-term moat — why the longitudinal dataset, not the hardware, becomes the company's most valuable asset. 
• The national health record vision — the case for a federated, interoperable record and hospital-at-home at scale. 

Key Insights 

• Prevention is cheaper than almost anyone realizes, and the system ignores it anyway. A urinary tract infection caught early costs roughly $20 in antibiotics; missed, it can escalate to sepsis, a multi-week hospital stay near $20,000, and meaningful mortality risk — yet nothing in the funding model rewards catching it early. 
• The hard part isn't the AI, it's the clinical plumbing. Alerts are useful only if they appear in the workflows clinicians already use. That's why CHA sends its signals through the same electronic record that their teams have trusted for years, instead of asking busy staff to learn something new. 
• Owning the data eventually matters more than owning the device. Today, CHA is essentially an assistive tool with clinicians making every decision. Still, the continuous, anonymized picture of aging its building could become a defensible asset — even an early-warning system for the next pandemic. 

Links 

• Scaling with Clarity Podcast: https://www.linkedin.com/showcase/futureventures-podcast/ 
• CHA Group / CHAH AI Care: https://chah.ai/ 
• Robert Stanley on LinkedIn: https://www.linkedin.com/in/rjastanley/ 
• Future Ventures Corp: https://www.linkedin.com/company/future-ventures-corp 
• Watch on YouTube: https://youtu.be/OInk-HpvUOc 

About Robert Stanley 

Robert Stanley is the Founder and CEO of CHA Group, the parent company of State Home Nursing Care Services and CHA Technology. After a long career in technology delivering large-scale IT projects, he moved into home care a decade ago. He built one of Ontario's established providers before turning his focus to predictive, technology-enabled care. Today, he's pioneering Comprehensive Healthcare at Home, a model that combines AI-powered monitoring with clinical response to keep vulnerable seniors safe, independent, and out of the hospital. 

This podcast has been brought to you by the Capital Intelligence Platform: capital.futureventures.ca

Send us Fan Mail

Greg Miles is the founder and CEO of Milestone Gyno-Mics, a biotech company developing the first AI-powered, non-invasive blood test for endometriosis. He is one of the first bioinformatics PhDs in the U.S., with over 15 years of experience in genomics, diagnostics, and AI. He left a 10-year job at Agilent to focus on this project. His motivation is personal: he lost both grandparents to leukemia that was diagnosed too late, and he watched a loved one struggle for 12 years seeing many doctors before finally being diagnosed with endometriosis by a surgeon. 

This conversation matters because endometriosis affects more than 1 in 10 women, is the leading cause of infertility, and is invisible on imaging more than 95% of the time — leaving most women on a decade-long diagnostic odyssey. Greg's thesis is blunt: endometriosis behaves like cancer (a recent paper found it shares all eight hallmarks), so we should detect it like cancer. The result is a clear-eyed look at why women's health has been underfunded and overlooked, how AI changes the math on early detection, and why the next major breakthrough in medicine may be diagnosis, not treatment. 

Key Topics Covered 

1. The diagnostic gap in women's health — Why early detection exists for breast cancer but almost nowhere else, and what that absence costs women in lost years and lost fertility. 
2. Endometriosis as a cancer-like disease — How endo shares all eight hallmarks of cancer, and why that reframing should change how we diagnose and treat it. 
3. How the AI blood test works — Reading three distinct biological signals from a simple arm draw and using machine learning to turn 20,000+ data points into a single diagnostic signature. 
4. The economics of delayed diagnosis — The roughly $200K-per-patient cost of a 10-year delay, and why insurers, fertility clinics, and employers all have skin in the game. 
5. What investors should actually scrutinize — The four things that separate a real diagnostic from a hyped one, from sensitivity and specificity to the integrity of the held-out data. 

Key Insights 

• Early detection is the key to everything downstream. Catch endometriosis in the first couple of years, and hormone therapy and surgery are far more likely to work; wait, and the disease spreads, recurs, and can close the window to start a family. 
• The "yellow light" problem is the tell. Plenty of companies tout 90% accuracy while quietly parking 30–50% of patients in an inconclusive bucket — and no insurer pays for a test that can't commit to an answer. 
• Repurposed drugs may be the fast track to treatment. Because endometriosis is a systemic, inflammatory disease recently linked to some 600 comorbidities, existing drugs with cleared safety profiles — GLP-1s among them — could leap straight toward endometriosis trials. 

Links 

• Milestone Gyno-Mics: https://www.milestonegx.com/ 
• Connect with Greg Miles: https://www.linkedin.com/in/gregory-miles 
• Scaling with Clarity: https://www.linkedin.com/showcase/futureventures-podcast/

About the Guest 

Greg Miles is the founder and CEO of Milestone Gyno-Mics, a biotechnology company developing a non-invasive, AI-powered blood diagnostic platform for women's health. One of the first bioinformatics PhDs trained in the United States, he brings more than 15 years of experience across genomics, diagnostics, and artificial intelligence, including a decade at Agilent. His mission is to collapse the years-long diagnostic delay women face for conditions like endometriosis — starting with a single blood test.

Send us Fan Mail

Jan Poetsch spent almost twenty years working on some of the world's most complicated energy projects. He then realized that the biggest hidden opportunity in industrial energy was right on the income statement: the power bill. His career took him from a small town in Germany to offshore platforms with Shell, the Sakhalin II project in Russia, and the LNG Canada supply chain. These big projects taught him where the money often leaks out unnoticed. In late 2023, he started Arder Energy to target one of the biggest costs that most industrial companies still ignore. 

The timing of this conversation is hard to overstate. Alberta just logged 34 straight hours of $0.00/MWh power — a market record — while data centers alone are about to add a load equal to six years of normal demand growth. The operators still treating electricity as a passive flow-through cost are about to get caught flat-footed. Jan makes a sharp, practical case for why power is now a strategic lever rather than a line item, and what the smartest industrial players are already doing about it. 

Key topics covered 

• From Germany to the oil sands — Jan's journey through Shell, Sakhalin II, and LNG Canada, and the moment he realized power was the most under-managed cost in industry. 
• Inside Alberta's wild power market — 34 hours at zero, an "islanded" grid, and prices that swing from the floor to nearly $1,000/MWh. 
• How Arder finds the wins — a top-down "green/amber/red" screen that surfaces 5–10% savings before anyone touches capital. 
• Why industrial heat is so hard to decarbonize — and how brick "toasters," electrode boilers, and thermal storage rewrite the economics. 
• Canada's energy superpower question — what it actually takes, why Texas is the model, and where nuclear really fits. 

Key insights 

1. Power has quietly become strategic. Most firms run "set-and-forget" energy contracts while sweating far smaller costs — yet a single 15-minute window can drive half a month's transmission bill, and the levers to manage it are sitting right there unused. 
2. Speed beats perfection. Arder deliberately chases a high cadence of smaller, self-funding wins over a 200-page strategy report. The first project pays for the next, so clients carry almost no downside risk. 
3. Reward outcomes, not technologies. When policy picks winners, it distorts the market — cheaper, simpler decarbonization paths lose out to carbon capture on the subsidy structure rather than merit. 

Links 

• Arder Energy — https://www.linkedin.com/company/arder-energy/ 
• Jan Poetsch on LinkedIn — https://www.linkedin.com/in/jan-poetsch-1206791a/ 
• Future Ventures Corp — https://linkedin.com/company/future-ventures-corp 

About the guest 

Jan Poetsch is the founder and CEO of Arder Energy. He helps industrial companies and investors turn their energy costs from a regular expense into a strategic advantage. Before starting Arder in 2023, he spent nearly 20 years working in global LNG and energy roles at Shell and PetroChina. He has experience working in Europe, Russia, and Canada on projects like Sakhalin II and LNG Canada. He combines business strategy with hands-on experience in industrial engineering, finance, and operations. 

Send us Fan Mail

Jeremy Funk has spent more than two decades doing the one thing most people in tech were told to stop prioritizing: building real relationships. As founder and CEO of Funk Futures — a fractional sales, recruiting, and marketing firm rooted in the energy sector — he's earned a reputation as one of the industry's premier "super connectors." His value, as he puts it plainly, is the people in his phone who actually pick up when he calls. Based in Boulder County, Colorado, and a veteran of 85 cold calls a day early in his career, Jeremy built his business on a single non-negotiable pillar: authenticity. 

This conversation is important because Jeremy is using an innovative approach. As AI handles more outreach, skills like listening, curiosity, and real connection become the most valuable. For entrepreneurs trying to get big clients, build a sales process, or stand out in a world full of chatbots, Jeremy gives honest, simple advice on doing business the human way. It's part sales tips, part life lesson on building careers and raising kids in a tech-driven world. 

Key Topics Covered 

1. The relationship-first career — Why Jeremy bet on connection over coding, and how 85 cold calls a day became the foundation for everything that followed. 
2. Authenticity as a sales strategy — How telling clients the truth instead of what they want to hear became Funk Futures' number-one differentiator. 
3. Winning enterprise rapport — Doing the research, meeting buyers where they are, and turning transactional conversations into personal ones. 
4. AI as an opening, not a threat — Why mass automation has made cold calling and authentic outreach more valuable, not less. 
5. Raising connectors in a screen-first world — Phone-free summer camps, no-phone dinners, and a daughter's lawn-mowing hustle as a real lesson in selling. 

Key Insights 

• The best salespeople run on a "two big ears, one small mouth" rule — they ask and listen far more than they pitch, because understanding why someone would buy matters more than describing what you're selling. 
• AI removes friction and saves time, so buyers will increasingly expect it — but that same automation creates an opening, because the more robotic everything feels, the more people crave doing business with an actual human. 
• You're always investing in people, not products or technology; resilience forged through real adversity — getting fired, losing deals, persevering anyway — is the trait that most reliably separates great founders from the rest. 

Links 

• Funk Futures: https://www.funkfutures.com/ 
• Jeremy Funk on LinkedIn: https://www.linkedin.com/in/jeremyfunk 
• Future Ventures Corp: https://www.linkedin.com/company/future-ventures-corp/ 

About the Guest 

Jeremy Funk is the founder and CEO of Funk Futures, a fractional sales, recruiting, and marketing firm that helps innovative companies — particularly in energy — accelerate sales, recruit top talent, and expand their market presence. A Brandeis University graduate with more than 20 years in technology and energy sales, he's recognized as one of the industry's premier connectors and a trusted advisor to founders and executives. He lives in Boulder County, Colorado, with his wife and three kids, where he's a die-hard Boston sports fan and host of multiple podcasts.

Send us Fan Mail

Emilia de Stasio spent years working in finance at places like the European Central Bank and Moody's, but she later turned her focus to a market that has very little data. As a long-time art collector, she often found it hard to get reliable information to decide if a piece was a good buy. Frustrated by this, she co-founded Artscapy, a platform that aims to bring clarity, organization, and data to an industry that's usually known for being secretive and exclusive. 

This conversation is important because Emilia is in a unique position. She understands both how to build a portfolio and weigh risks versus rewards, but she also cares about art genuinely and refuses to let the financial side ignore the human aspect. Her approach offers a straightforward guide for anyone wondering if art has a place in a serious investment portfolio, how to include it without getting burned, and what it takes to shake up an industry that's been resistant to change for many years. For founders and investors, it also teaches how to create a strong data advantage and use AI to generate real value. 

Key topics covered 

• The origin story of Artscapy — how a personal frustration with the lack of honest data turned a side project for collector friends into a global platform with 15,000 members. 
• Building data in an opaque market — why clean, standardized data, not raw volume, is the hardest part of making the art market legible. 
• Art as an asset class — how diversification, thematic collecting, and uncorrelated returns make art a credible portfolio component without stripping out the passion. 
• Securitization and liquidity — how Artscapy lets collectors unlock capital from their art without being forced to sell at the wrong moment. 
• AI's real role in art — where AI transforms the art market and where it can never replace the human core of great work. 

Key insights 

1. Art is not a single, homogeneous asset. Treating a collection like a guaranteed appreciation play is a mistake; like equities, outcomes depend on research, diversification, and the discipline to walk away from most opportunities. 
2. The case for art is strongest when the financial and the personal coexist. Its low connection with other assets makes it a good fit for a modern portfolio, but its lasting value comes from owning something you truly want to keep for ten years or more. 
3. AI will never produce great art, but it has already changed how art is bought. Great art is fundamentally human, so AI struggles to create work with real depth; its true power is synthesizing millions of data points faster than any human, which is exactly where Artscapy applies it. 

Links 

• Emilia de Stasio: https://www.linkedin.com/in/emilia-de-stasio/ 
• Artscapy: https://artscapy.com/home 
• Future Ventures Corp: https://ca.linkedin.com/company/future-ventures-corp 

About the guest 

Emilia de Stasio is the co-founder and COO of Artscapy, a platform that makes it easier for people to buy, manage, finance, and invest in art. She has experience working at the European Central Bank, Moody's, and family offices that invest in alternative assets. Emilia is passionate about collecting art and wants to make the art market more open, understandable, and based on data.

Send us Fan Mail

Dave Guttman has spent more than three decades building, scaling, acquiring, and exiting businesses — racking up multiple 8- and 9-figure outcomes along the way. But the thing that shaped how he operates wasn't a deal. At 24, fresh off an acceptance to Wharton, three doctors misdiagnosed him and told him he had six months to live. He survived, and the experience rewired his definition of success from accumulation to impact. That shift is the throughline of this conversation. 

Why this one matters: Guttman is rare in that he speaks fluently in both registers founders actually need — the hard mechanics of raising capital, building budgets, and engineering an exit, and the harder questions of what you're scaling toward in the first place. He's blunt about where most founders go wrong (no financial model, raising too little money, mistaking confidence for competence), candid about AI as both a force multiplier and a genuine risk, and refreshingly unsentimental about legacy. If you're scaling a company and quietly wondering whether the climb is worth it, this is a conversation worth your time. 

Key Topics Covered 

• The misdiagnosis that reset everything — How a death sentence at 24 reframed his entire approach to work, relationships, and what he was building for. 
• Raising capital the right way — Why he argues raising $5M is easier than $500K, and the break-even math most founders get backwards. 
• AI as a creative force multiplier — How he built a 100-page business plan in three hours and is co-writing two books in months instead of years. 
• The coming collapse of traditional education — Why he begged his daughter not to go to college and where he thinks learning is actually headed. 
• Fortune vs. specialness — His case for radical humility, and the legacy question he poses that stops most people cold. 

Key Insights 

1. Self-awareness beats raw skill. Being weak in an area of your business is survivable; believing you're strong where you're actually weak is what kills companies. Knowing the difference is the founder's real edge. 
2. Capital needs come before valuation, not after. Most founders fixate on their valuation first, then back into a raise. Guttman flips it — figure out two to three times what you genuinely need to reach break-even, because running out of cash is the business equivalent of a plane running out of fuel. 
3. AI rewards people who already know the hard way. The tools are a multiplier on existing expertise and creativity, not a substitute for them, which is why those who learned to do the work the slow way may end up with the biggest advantage. 

Links & Resources 

• Full episode: https://youtu.be/DreXyifEPBs 
• Dave Guttman — https://www.linkedin.com/in/drguttman/ 
• Future Ventures Corp: https://ca.linkedin.com/company/future-ventures-corp

Send us Fan Mail

Dr. Samir Musayev has built a career helping businesses think well beyond their home turf. As Commercial Account Director at Export Development Canada (EDC), he works hands-on with Canadian companies navigating the messy reality of global trade — financing, risk, and the practical mechanics most founders badly underestimate. Originally from Baku, Azerbaijan, and now based in Calgary, he brings an international lens shaped by years in finance and business development across borders. He also hosts the Global Nomads podcast, where he unpacks entrepreneurship, leadership, and the stories of people building companies across borders. 

This episode explains why many Canadian companies want to start exporting but often don't follow through. The reasons are usually different from what founders expect. Samir says the main challenges are not money, but lack of knowledge, paperwork problems, and thinking export is just a one-time effort instead of a long-term plan. With tariffs changing the Canada–US relationship and the need to diversify, this episode offers practical advice for any founder wanting to expand beyond Canada. 

Key Topics Covered 

1. The immigrant networking playbook — Why building a network from scratch takes double the effort, and how to actually stay top of mind once the event is over. 
2. Why Canadian companies stall on export — The knowledge gaps and unfamiliar trade mechanics (bills of lading, Incoterms, getting paid) that quietly kill international ambitions. 
3. Picking the right market — Why the "sexy" developed markets are often the wrong bet, and where real, under-penetrated demand actually hides. 
4. Getting paid across borders — The crucial difference between a buyer's inability and unwillingness to pay, and how AR insurance and documentary credits de-risk it. 
5. Tariffs, diversification, and the future of trade — What CUSMA renegotiation could mean, plus where AI does and doesn't help a still-paper-based industry. 

3 Key Insights 

1. Export holds up a mirror to your company. Cracks you can hide in a forgiving domestic market — sloppy paperwork, thin processes — get exposed the moment you go global. Build the company to export from the start; don't bolt it on later. 
2. More companies die from growth than from recessions. A $50 million contract can ruin a $10 million business if it can't handle the execution, cover the working capital, or manage the extra staff needed. Selling more doesn't help if you can't deliver—it's a liability, not a success. 
3. The cheapest risk to ignore is the one that ends you. A single unpaid six-figure invoice can take down an otherwise healthy exporter — and quotes for receivables insurance are usually free, so there's little excuse not to price it. 

Links & Resources 

• Connect with Dr. Samir Musayev on LinkedIn: https://www.linkedin.com/in/musayevs/ 
• Global Nomads Podcast (YouTube): https://www.youtube.com/@TheGlobalNomadsPodcast 
• Export Development Canada (EDC): https://www.edc.ca/ 
• Future Ventures Corp: https://www.linkedin.com/company/future-ventures-corp 

About the Guest 

Dr. Samir Musayev is a Commercial Account Director at Export Development Canada. He helps Canadian companies get funding, reduce risks, and grow into international markets. Originally from Baku, Azerbaijan, now living in Calgary, he has experience in finance and trade, helping businesses expand across borders. He also hosts the Global Nomads podcast, where he talks with entrepreneurs and professionals who are building their lives and businesses around the world.